Skip to main content

Table 2 Univariate and multivariate regression analysis of prognostic factors correlated with postoperative OS

From: Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer

 

Univariable analysis

Multivariable analysisa

Multivariable analysisb

Variables

HR (95%CI)

P value

HR (95%CI)

P value

HR (95%CI)

P value

Gender

 Female

Reference

     

 Male

1.10 (0.73 to 1.66)

0.640

    

Age

  < 60 years

Reference

     

  > 60 years

1.30 (0.85 to 1.99)

0.223

    

Gall stone

 Absent

Reference

     

 Present

1.36 (0.91 to 2.06)

0.137

    

Tumor size

 < 3 cm

Reference

     

 > 3 cm

1.15 (0.76 to 1.73)

0.513

    

TNM stage

 Low (I.II. III)

Reference

 

Reference

 

Reference

 

 High(IV)

6.11 (3.84 to 9.72)

 < 0.001

4.04 (2.07to7.87)

 < 0.001

4.14 (2.12 to 8.09)

 < 0.001

Surgical margin

 R0

0.16 (0.10 to 0.25)

 < 0.001

0.51 (0.28to0.92)

0.026

0.51 (0.28 to 0.92)

0.025

 R1

Reference

 

Reference

 

Reference

 

Adjuvant therapy

 Present

1.14 (0.74 to 1.73)

0.555

0.58 (0.36to0.92)

0.021

0.59 (0.37 to 0.94)

0.027

 Absent

Reference

 

Reference

 

Reference

 

Histologic differentiation

 Moderate. Well

Reference

 

Reference

 

Reference

 

 Poor

7.04 (4.36 to 11.36)

 < 0.001

5.06 (3.00to8.55)

 < 0.001

5.05 (3.00 to 8.53)

 < 0.001

TIM3

 Low

Reference

 

Reference

   

 High

1.57 (1.03 to 2.38)

0.036

1.16 (0.70to1.91)

0.561

  

PD1

 Low

Reference

 

Reference

   

 High

2.15 (1.37 to 3.36)

 < 0.001

1.54 (0.91to2.62)

0.111

  

GROUP

 GROUPI

Reference

   

Reference

 

 GROUPII

1.56 (0.88 to 2.77)

0.13

  

1.54 (0.86 to 2.76)

0.142

 GROUPIII

2.27 (1.36 to 3.77)

0.002

  

1.80 (1.08 to 3.02)

0.025

  1. GROUPI,PD1low/TIM3low; GROUPII, PD1high/TIM3low or PD1low/TIM3high; GROUPIII, PD1high/TIM3high
  2. Bold values indicates statistically significant
  3. Multivariable analysis a: PD1, TIM3 and other significant clinicopathological characteristics
  4. Multivariable analysis b: GROUP and other significant clinicopathological characteristics